Taking Sabril® (vigabatrin)

For Refractory CPS Patients

Sabril is available in 500 mg tablets or as packets of 500 mg powder for oral solution. It is taken by mouth with or without food. Either tablet or powder can be used for adults and children 10 years of age or older with refractory CPS. Your doctor will tell you how much to take each day. Ask your doctor what you should do if a dose is missed. Be sure to tell your doctor if you or your child has any side effect that bothers you or that does not go away. Please read the Medication Guide that comes with the prescription before starting Sabril, and with each refill, as there may be new information.

All people who take Sabril are at risk for permanent vision loss with any amount of Sabril.

For Infantile Spasms Patients

Sabril comes in a powder form that you mix with water. Your baby will take Sabril by mouth. Your doctor will tell you how much medicine to give your baby. Talk with your doctor if you have any questions about the right dose of medicine to give your baby or how to mix it.

All people who take Sabril are at risk for permanent vision loss with any amount of Sabril.

SABRIL® (vigabatrin) Tablets and Powder for Oral Solution

Use

SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the risk of vision loss. SABRIL should not be the first medicine used to treat CPS.

SABRIL (vigabatrin) is a prescription medicine used in babies, 1 month to 2 years old, with infantile spasms (IS), if the possible benefits outweigh the possible risk of vision loss.

IMPORTANT
SAFETY INFORMATION

EXPAND

WARNING: PERMANENT VISION LOSS

See Medication Guide and full Prescribing Information for complete information.

All people who take SABRIL:

  • You are at risk for vision loss with any amount of SABRIL.
  • Your risk of vision loss may be higher the more SABRIL you take daily and the longer you take it.
  • It is not possible for your healthcare provider to know when vision loss will happen. It could happen soon after starting SABRIL or any time during treatment. It may even happen after treatment has stopped.

IMPORTANT
SAFETY INFORMATION

COLLAPSE

WARNING: PERMANENT VISION LOSS

See Medication Guide and full Prescribing Information for complete information.

All people who take SABRIL:

  • You are at risk for vision loss with any amount of SABRIL.
  • Your risk of vision loss may be higher the more SABRIL you take daily and the longer you take it.
  • It is not possible for your healthcare provider to know when vision loss will happen. It could happen soon after starting SABRIL or any time during treatment. It may even happen after treatment has stopped.

 

 

 

For more information, please see SABRIL Medication Guidefull Prescribing Information including Boxed Warning for risk of permanent vision loss, and Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The product information provided in this site is intended only for residents of the U.S. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. Sabril may not be a fit for everyone. You and your doctor should decide if the possible benefits of taking Sabril are more important than the risk of permanent vision loss.

©2020 Lundbeck. All rights reserved. VGB-B-100004v5

Sabril is a registered trademark of Lundbeck